Aquestive Therapeutics reported revenue of $13.82M and net income of -$22.86M for the quarter ended Jun 2026, up 38.1% year over year. This income statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | 13.29M | 11.08M | 12.27M | 13.27M | 11.46M | 10.68M | 11.13M | 13.24M | 13.00M | 13.21M | 12.05M | 20.10M | 13.54M | 11.87M | 8.72M | 10.00M | 12.81M | 13.02M | 14.45M | 13.82M | |||||||||||||||||
| Cost of RevenueCost of Rev | 4.40M | 3.37M | 4.21M | 5.24M | 4.62M | 5.30M | 4.74M | 6.62M | 4.80M | 5.48M | 4.39M | 4.53M | 4.44M | 4.52M | 3.65M | 4.56M | 4.51M | 5.84M | 3.47M | 4.02M | |||||||||||||||||
| Gross Profit | 8.89M | 7.71M | 8.06M | 8.02M | 6.84M | 5.38M | 6.40M | 6.62M | 8.20M | 7.72M | 7.66M | 15.57M | 9.11M | 7.35M | 5.07M | 5.44M | 8.30M | 7.18M | 10.98M | 9.80M | |||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 4.73M | 4.40M | 4.77M | 5.20M | 3.23M | 4.28M | 3.55M | 3.47M | 3.20M | 2.89M | 5.93M | 4.16M | 5.27M | 4.92M | 5.36M | 4.11M | 4.53M | 3.20M | 4.20M | 3.96M | |||||||||||||||||
| Selling, General & AdministrativeSG&A | 12.13M | 14.98M | 13.02M | 15.59M | 12.46M | 11.81M | 7.46M | 7.36M | 7.38M | 9.55M | 10.69M | 11.36M | 12.13M | 16.01M | 19.07M | 12.71M | 15.25M | 32.82M | 10.98M | 14.06M | |||||||||||||||||
| Other Operating ExpensesOther Opex | 4.40M | 3.37M | 4.21M | 5.24M | 4.62M | 5.30M | 4.74M | 6.62M | 4.80M | 4.68M | 4.39M | 4.53M | 4.44M | 4.52M | 3.65M | 4.56M | 4.51M | 5.84M | 3.47M | 4.02M | |||||||||||||||||
| Operating ExpensesOpex | 21.25M | 22.75M | 22.01M | 26.03M | 20.32M | 21.39M | 15.74M | 17.45M | 15.38M | 17.12M | 21.01M | 20.04M | 21.83M | 25.45M | 28.09M | 21.37M | 24.29M | 41.85M | 18.65M | 22.04M | |||||||||||||||||
| Operating IncomeOp. Inc | -7.97M | -11.67M | -9.74M | -12.76M | -8.85M | -10.71M | -4.61M | -4.21M | -2.38M | -3.91M | -8.96M | 0.06M | -8.29M | -13.58M | -19.36M | -11.37M | -11.48M | -28.84M | -4.20M | -8.22M | |||||||||||||||||
| EBIT | -7.97M | -11.67M | -9.74M | -12.76M | -8.85M | -10.71M | -4.61M | -4.21M | -2.38M | -3.91M | -8.96M | 0.06M | -8.29M | -13.58M | -19.36M | -11.37M | -11.48M | -28.84M | -4.20M | -8.22M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 2.79M | 1.74M | 1.62M | 1.64M | 1.65M | 1.65M | 1.44M | 1.37M | 1.26M | 2.27M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.90M | 2.81M | |||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | -0.03M | 0.14M | -0.00M | 0.03M | 0.01M | 0.07M | 14.51M | 0.13M | 1.51M | 0.17M | 0.33M | 1.40M | 0.98M | 0.73M | 0.71M | 2.10M | 0.31M | 1.25M | 0.08M | 0.88M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 13.82M | -0.35M | -1.03M | -11.68M | |||||||||||||||||||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | -14.55M | -28.95M | -13.22M | -16.30M | -12.54M | -12.35M | 8.07M | -5.51M | -2.17M | -8.01M | -12.83M | -2.75M | -11.51M | -17.07M | -22.93M | -13.55M | -15.45M | -31.86M | -8.06M | -22.86M | |||||||||||||||||
| Tax ProvisionsTaxes | 0.28M | -0.14M | 0.10M | -0.01M | |||||||||||||||||||||||||||||||||
| Profit After TaxPAT | -14.55M | -28.95M | -13.22M | -16.30M | -12.54M | -12.35M | 8.07M | -5.79M | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M | -17.05M | -22.93M | -13.55M | -15.45M | -31.86M | -8.06M | -22.86M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -14.55M | -28.95M | -13.22M | -16.30M | -12.54M | -12.35M | 8.07M | -5.79M | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M | -17.05M | -22.93M | -13.55M | -15.45M | -31.86M | -8.06M | -22.86M | |||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -14.55M | -28.95M | -13.22M | -16.30M | -12.54M | -12.35M | 8.07M | -5.79M | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M | -17.05M | -22.93M | -13.55M | -15.45M | -31.86M | -8.06M | -22.86M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -14.55M | -28.95M | -13.22M | -16.30M | -12.54M | -12.35M | 8.07M | -5.79M | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M | -17.05M | -22.93M | -13.55M | -15.45M | -31.86M | -8.06M | -22.86M | |||||||||||||||||
| Preferred Dividend PaymentsPref Dividends | |||||||||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -14.55M | -28.95M | -13.22M | -16.30M | -12.54M | -12.35M | 8.07M | -5.79M | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M | -17.05M | -22.93M | -13.55M | -15.45M | -31.86M | -8.06M | -22.86M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.37 | -0.76 | -0.32 | -0.36 | -0.23 | -0.25 | 0.15 | -0.10 | -0.03 | -0.13 | -0.17 | -0.03 | -0.13 | -0.20 | -0.24 | -0.14 | -0.14 | -0.30 | -0.07 | -0.18 | |||||||||||||||||
| EPS (Diluted) | -0.37 | -0.76 | -0.32 | -0.36 | -0.23 | -0.25 | 0.11 | -0.10 | -0.03 | -0.13 | -0.17 | -0.03 | -0.13 | -0.20 | -0.24 | -0.14 | -0.14 | -0.30 | -0.07 | -0.18 | |||||||||||||||||
| Shares Outstanding | 39.22M | 38.08M | 41.47M | 45.46M | 53.42M | 48.73M | 55.63M | 57.35M | 64.68M | 61.26M | 73.61M | 90.91M | 91.08M | 86.73M | 95.50M | 99.33M | 110.58M | 106.93M | 122.61M | 124.99M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 39.22M | 38.08M | 41.47M | 45.46M | 53.42M | 48.73M | 73.79M | 57.35M | 64.68M | 61.26M | 73.61M | 90.91M | 91.08M | 86.73M | 95.50M | 99.33M | 110.58M | 106.93M | 122.61M | 124.99M | |||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 40.08M | 41.23M | 41.62M | 53.34M | 53.85M | 54.83M | 55.92M | 61.62M | 66.74M | 68.53M | 73.61M | 91.06M | 91.18M | 91.41M | 99.32M | 99.35M | 121.66M | 122.04M | 124.28M | 125.51M | |||||||||||||||||
| EBITDA | -7.97M | -11.67M | -9.74M | -12.76M | -8.85M | -10.71M | -4.61M | -4.21M | -2.38M | -3.91M | -8.96M | 0.06M | -8.29M | -13.58M | -19.36M | -11.37M | -11.48M | -28.84M | -4.20M | -8.22M | |||||||||||||||||
| Interest ExpensesInt Expense | 2.79M | 1.74M | 1.62M | 1.64M | 1.65M | 1.65M | 1.44M | 1.37M | 1.26M | 2.27M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.78M | 2.90M | 2.81M | |||||||||||||||||
| Tax Rate | -5.16% | 6.44% | -1.26% | 0.08% |